Roozbeh Sharif

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. pmc Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
    Roozbeh Sharif
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Semin Arthritis Rheum 41:38-47. 2011
  2. pmc Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis
    Roozbeh Sharif
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    J Rheumatol 38:1622-30. 2011
  3. pmc Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
    Shervin Assassi
    Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
    PLoS ONE 6:e26061. 2011
  4. pmc Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
    Shervin Assassi
    Division of Rheumatology and Clinical Immunogenetics, University of Texas Houston, 6431 Fannin, Houston, TX 77030, USA
    Arthritis Res Ther 12:R166. 2010
  5. pmc IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
    Roozbeh Sharif
    Division of Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Ann Rheum Dis 71:1197-202. 2012
  6. pmc Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial
    Emily W Hung
    Rheumatology Associates of Houston, Division of Northwest Diagnostic Clinic, Houston, Texas, USA
    J Rheumatol 40:455-60. 2013
  7. pmc Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis
    Rajpreet K Arora-Singh
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX, USA
    J Autoimmun 35:52-7. 2010
  8. pmc Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5
    Shervin Assassi
    Department of Medicine, Division of Rheumatology, University of Texas Health Science Center, Houston, TX 77030, USA
    J Rheumatol 38:87-98. 2011
  9. pmc Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts
    Xiaodong Zhou
    Division of Rheumatology, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Arthritis Res Ther 13:R128. 2011

Collaborators

Detail Information

Publications9

  1. pmc Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort
    Roozbeh Sharif
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Semin Arthritis Rheum 41:38-47. 2011
    ..We hypothesized that WD in systemic sclerosis (SSc) is a function of demographic, clinical, and psychosocial factors...
  2. pmc Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis
    Roozbeh Sharif
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    J Rheumatol 38:1622-30. 2011
    ..We examined the immunogenetic, clinical, and survival correlates of AFA in a large group of AA patients with SSc...
  3. pmc Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
    Shervin Assassi
    Department of Medicine, Division of Rheumatology, University of Texas Health Science Center at Houston, Houston, Texas, United States of America
    PLoS ONE 6:e26061. 2011
    ..We also examined baseline predictors of change in fatigue severity over time...
  4. pmc Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
    Shervin Assassi
    Division of Rheumatology and Clinical Immunogenetics, University of Texas Houston, 6431 Fannin, Houston, TX 77030, USA
    Arthritis Res Ther 12:R166. 2010
    ....
  5. pmc IRF5 polymorphism predicts prognosis in patients with systemic sclerosis
    Roozbeh Sharif
    Division of Rheumatology, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Ann Rheum Dis 71:1197-202. 2012
    ..The goal of this study was to investigate the impact of these gene variants on survival and severity of interstitial lung disease (ILD) in SSc...
  6. pmc Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial
    Emily W Hung
    Rheumatology Associates of Houston, Division of Northwest Diagnostic Clinic, Houston, Texas, USA
    J Rheumatol 40:455-60. 2013
    ..To describe the prevalence and clinical correlates of endoscopic gastric antral vascular ectasia (GAVE; "watermelon stomach") in early diffuse systemic sclerosis (SSc)...
  7. pmc Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis
    Rajpreet K Arora-Singh
    Division of Rheumatology and Immunogenetics, University of Texas Health Science Center at Houston, Houston, TX, USA
    J Autoimmun 35:52-7. 2010
    ....
  8. pmc Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5
    Shervin Assassi
    Department of Medicine, Division of Rheumatology, University of Texas Health Science Center, Houston, TX 77030, USA
    J Rheumatol 38:87-98. 2011
    ..to identify differentially expressed genes in peripheral blood cells (PBC) of patients with ankylosing spondylitis (AS) relative to healthy controls and controls with systemic inflammation...
  9. pmc Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts
    Xiaodong Zhou
    Division of Rheumatology, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    Arthritis Res Ther 13:R128. 2011
    ..The aims of this study were to examine the catalytic function and sumoylation of topo I in the nuclei of SSc fibroblasts, a major cell type involved in the fibrotic process...